Montserrat Lonca
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine.
Journal: AIDS (London, England)
Published: July 24, 2019
A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity.
Journal: AIDS (London, England)
Published: May 11, 2018
Subclinical cardiovascular disease in patients starting contemporary protease inhibitors.
Journal: HIV medicine
Published: March 06, 2018
Tolerability of integrase inhibitors in a real-life setting.
Journal: The Journal of antimicrobial chemotherapy
Published: November 16, 2016
Zidovudine treatment in HIV-infected pregnant women is associated with fetal cardiac remodelling.
Journal: AIDS (London, England)
Published: February 27, 2016
Dolutegravir monotherapy in HIV-infected patients with sustained viral suppression.
Journal: The Journal of antimicrobial chemotherapy
Published: January 12, 2016
Pregnancy in a renal transplant recipient with HIV-1 infection: a case report.
Journal: Antiviral therapy
Published: September 13, 2015
Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir.
Journal: HIV medicine
Published: July 30, 2015
Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 02, 2015
Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients.
Journal: Antimicrobial agents and chemotherapy
Published: August 27, 2014
Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: June 05, 2014
Impact of prior virological failure and nucleos(t)ide genotypic resistance mutations on the efficacy of switching from ritonavir-boosted protease inhibitors to raltegravir.
Journal: Antiviral therapy
Published: May 06, 2014
Last Updated: 09/26/2026